The Small Biotech Scaring Big Pharma

Dear Fellow Investor, On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body. This revolutionary new kind of treatment will not just change medicine - It has the potential to eliminate genetic disease from our species. If that sounds like science fiction, consider this - The Nobel Prize Committee is calling it "The Holy Grail of Medicine" The Wall Street Journal reports the company is "transforming medicine." 60 Minutes reports the company is "revolutionizing the search for new drugs." And the biggest drug companies have rushed to invest over a $1 billion in one year alone - Juno Pharma invested $700 million. Glaxo SmithKline invested $350 million. Johnson and Johnson invested $292 million. That's on top of the $120 million Bill Gates and Google Ventures already invested into this. The list goes on and on... Never before has so much money invested in a new treatment so quickly. And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars. Investor's Business Daily estimates the market is worth at least $75 billion. But right now, its stock price is just a tiny fraction of that size. Our research proves that anyone who gets in today could make like-changing gains. That's if the company doesn't get taken over for fast 300% gains first. CLICK HERE to see how you can profit from this rare opportunity>>> "The Buck Stops Here,"   Behind the Markets is brought to you by Behind the Markets, LLC. If you have any questions, please contact us at support@behindthemarkets.com, or call at 800-851-1965. Behind the Markets is a newsletter offered to the public on a subscription basis.  While subscribers receive the benefit of Behind the Markets opinions, none of the information contained therein constitutes a recommendation from Behind the Markets that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person.   You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter.  To the extent any of the information contained in Behind the Markets may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  Behind the Markets’ past results are not necessarily indicative of future performance.  Employees of Behind the Markets are subject to certain restrictions in transacting for their own benefit. SPECIFICALLY, EMPLOYEES ARE NOT PERMITTED TO BUY OR SELL ANY SECURITY RECOMMENDED FOR THREE (3) TRADING DAYS FOLLOWING THE ISSUE OF A REPORT OR UPDATE. Behind the Markets’ Newsletter contains Behind the Markets’ own opinions, and none of the information contained therein constitutes a recommendation by Behind the Markets that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person.  You further understand that Behind the Markets will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter.  To the extent any of the information contained in Behind the Markets Newsletter may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  Behind the Markets’ past results are not necessarily indicative of future performance. DO NOT EMAIL Behind the Markets SEEKING PERSONALIZED INVESTMENT ADVICE, WHICH WE CANNOT PROVIDE.  The Editor's personal investing goals and risk tolerance may be substantially different from those discussed in the Newsletter and/or circumstances may have changed by the expiration of the three day restricted period, the investment actions taken by the Editor in the accounts the Editor directly or indirectly owns may vary from (and may even be contrary to) the advice and recommendations in the Newsletter. Investing involves substantial risk. Neither the Editor, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from using the Newsletter. While past performance may be analyzed in the Newsletter, past performance should not be considered indicative of future performance.  No subscriber should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing the prospectus and other public filings of the issuer.  To the maximum extent permitted by law, the Editor, the publisher and their respective affiliates disclaim any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations in the Newsletter prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses.  The Newsletter's commentary, analysis, opinions, advice and recommendations represent the personal and subjective views of the Editor and are subject to change at any time without notice. The information provided in the Newsletter is obtained from sources which the Editor believes to be reliable. However, the Editor has not independently verified or otherwise investigated all such information. Neither the Editor, the publisher, nor any of their respective affiliates guarantees the accuracy or completeness of any such information.  The Newsletter is not a solicitation or offer to buy or sell any securities. Further, the Newsletter is in no way intended to be a solicitation for any services offered by Behind the Markets  Neither the Editor, the publisher, nor any of their respective affiliates are responsible for any errors or omissions in the Newsletter.      Our mailing address is: Behind the Markets, LLC 4181 NW 1st Avenue, Suite 8 Boca Raton, FL 33431 Copyright © 2022 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. Unsubscribe